Annovera FDA Approval History
Last updated by Judith Stewart, BPharm on Jan 28, 2021.
FDA Approved: Yes (First approved August 10, 2018)
Brand name: Annovera
Generic name: ethinyl estradiol and segesterone acetate
Dosage form: Vaginal System
Company: The Population Council
Treatment for: Birth Control
Annovera (ethinyl estradiol and segesterone acetate) is an estrogen and progestin vaginal contraceptive system indicated to prevent pregnancy for up to a year.
Development timeline for Annovera
| Date | Article |
|---|---|
| Aug 10, 2018 | Approval FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
